髋关节镜翻修术:适应证识别与平均5年随访结局
单中心病例系列(证据等级4)回顾2012至2019年因股骨髋臼撞击综合征行髋关节镜翻修术的173例患者,翻修首要指征为残留撞击(67.8%),平均随访5.2年患者报告结局显著改善,但囊膜不稳定亚组术前及术后功能更差,再翻修率6.4%、转为全髋关节置换率6.9%。
要点
- 翻修髋关节镜最常见指征为残留股骨髋臼撞击(67.8%),其次为囊膜不稳定(14.6%)。
- 翻修术后平均5.2年,改良Harris髋关节评分等患者报告结局较术前显著改善。
- 囊膜不稳定亚组术后国际髋关节结局工具-33、髋关节结局评分-日常生活活动及改良Harris髋关节评分显著更差。
核心结论
- 治疗股骨髋臼撞击综合征时,髋关节镜翻修最常见指征仍为残留撞击。
- 囊膜不稳定对功能有显著不良影响,可能代表翻修关节镜术前及术后功能更差的一个患者亚组。
研究设计与样本
- 单中心病例系列,证据等级4。
- 回顾单中心髋关节保留登记数据库,纳入2012年至2019年因股骨髋臼撞击综合征行髋关节镜翻修术的患者。
- 共173例患者符合纳入标准,收集术前及术后平均5.2年随访的患者报告结局。
主要发现
- 翻修前4位主要指征为:残留股骨髋臼撞击67.8%、囊膜不稳定14.6%、异位骨化4.6%、粘连4.2%。
- 指征构成随时间未见变化。
- 患者术后较术前显著改善:改良Harris髋关节评分平均改善21.7(95%CI 18.6-24.7),髋关节结局评分-日常生活活动改善15.3(95%CI 12.1-18.5),髋关节结局评分-运动特异亚量表改善24.1(95%CI 19.2-29.1),国际髋关节结局工具-33改善30.7(95%CI 26.6-34.9),P<.001。
- 达到最小临床重要差异的比例为67.2%至82.1%,达到实质性临床获益的比例为41%至56%,末次随访时按绝对值达到实质性临床获益的比例为45%至64.8%。
- 亚组分析中,囊膜不稳定组术前功能仅以髋关节结局评分-运动特异亚量表衡量时显著低于撞击组(P=.004);术后囊膜不稳定组国际髋关节结局工具-33(P=.018)、髋关节结局评分-日常生活活动(P=.015)及改良Harris髋关节评分(P=.024)显著更差;但不同翻修指征间患者报告结局评分的术前至术后净变化无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the number of hip arthroscopy cases performed annually continues to rise, so does the number of patients requiring revision surgery. Determining the cause of failed hip arthroscopy (HA) can be challenging, with residual femoroacetabular impingement (FAI) being the most common indication for revision. While addressing impingement during primary HA is critical, factors such as articular cartilage defects, labral pathology, and capsular management also influence outcomes. PURPOSE: To evaluate trends in revision hip arthroscopy indications at a single institution and assess whether outcomes differ by the primary indication for revision. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A single-center hip preservation registry was reviewed to identify patients who underwent revision hip arthroscopy for FAI between 2012 and 2019. Patient demographics and primary indications for revision hip arthroscopy were determined, and patient-reported outcomes were collected preoperatively and at a mean follow-up of 5.2 years postoperatively. RESULTS: A total of 173 patients met inclusion criteria for this study. The top 4 primary indications for revision were as follows: residual FAI, 67.8%; capsular instability, 14.6%; heterotopic ossification, 4.6%; and adhesions, 4.2%. Trends in indication did not vary over time. On average, patients significantly improved pre- to postoperatively in the modified Harris Hip Score (21.7; 95% CI, 18.6-24.7), Hip Outcome Score (HOS)-Activities of Daily Living (15.3; 95% CI, 12.1-18.5), HOS-Sport-Specific Subscale (24.1; 95% CI, 19.2-29.1), and International Hip Outcome Tool-33 (30.7; 95% CI, 26.6-34.9; P < .001). Rates of achieving the minimal clinically important difference varied from 67.2% to 82.1%, the substantial clinical benefit from 41% to 56%, and the substantial clinical benefit by absolute value at final follow-up from 45% to 64.8%. In the subgroup analysis, significantly lower preoperative function was noted in the capsular instability cohort when compared with the impingement cohort, as measured by only the HOS-Sport-Specific Subscale (P = .004). Postoperatively, the capsular instability cohort demonstrated significantly worse outcomes as measured by the International Hip Outcome Tool-33 (P = .018), HOS-Activities of Daily Living (P = .015), and modified Harris Hip Score (P = .024). However, there was no significant difference in the net change in pre- to postoperative patient-reported outcome scores when the different indications for revision HA were compared. The rate of re-revision arthroscopy was 6.4%, and 6.9% of patients converted to total hip arthroplasty at a mean age of 40 years. CONCLUSION: The most common indication for revision hip arthroscopy in the treatment of femoroacetabular impingement remains residual impingement. Capsular instability has significant consequences for function and may represent a subset of patients who demonstrate more dysfunction before and after revision arthroscopy.
引用
- Selley RS, Baker HP, Burger JA, et al. Revision Hip Arthroscopy: Identifying Indications and Outcomes With a Mean 5-Year Follow-up. Am J Sports Med. 2025. PMID: 41105462. doi:10.1177/03635465251381775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。